ASTRAZENECA'S VACCINE SAFE AND EFFECTIVE : EUROPEAN MEDICAL AGENCY

  • 18/03/2021

The European Union's drug regulatory agency said Thursday that the AstraZeneca vaccine is not linked to an overall increase in the risk of blood clots and that the benefits of use outweigh the risks, paving the way for European countries to resume administering the shots.

Several European countries had suspended the use of the vaccine over the past week following reports of rare types of blood clots occurring in a small number of the millions of people who had received the shot across the continent.Germany, France and others had said they wanted to wait for the European Medicines Agency's determination before deciding whether to resume using the vaccine.

Related News